BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Preclinical models and technologies to advance nanovaccine development. Adv Drug Deliv Rev 2021;172:148-82. [PMID: 33711401 DOI: 10.1016/j.addr.2021.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Adv Drug Deliv Rev 2022;183:114140. [PMID: 35134434 DOI: 10.1016/j.addr.2022.114140] [Reference Citation Analysis]
2 Du Y, Song T, Wu J, Gao XD, Ma G, Liu Y, Xia Y. Engineering mannosylated pickering emulsions for the targeted delivery of multicomponent vaccines. Biomaterials 2022;280:121313. [PMID: 34894583 DOI: 10.1016/j.biomaterials.2021.121313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li S, Wang S, Tian B, Li N, Chen Y, Liu Y, Su W, Fan Y, Piao Y, Li J, Wang L, Zhao J, Wang S, Shi Y, Xiang R. Enhancement of tumor immunogenicity by the introduction of non- proteinogenic amino acid azetidine-2-carboxylic acid. OncoImmunology 2022;11:2097460. [DOI: 10.1080/2162402x.2022.2097460] [Reference Citation Analysis]